SCHEMBL24455243

SCHEMBL24455243

CCC(=O)N1Cc2ccccc2C2=C(CCCC2)c2ccccc21

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.57
HTT P42858 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
HSD17B3 P37058 3/20 0.42
ALDH1A1 P00352 4/20 0.41
TSHR P16473 3/20 0.41
MAPK1 P28482 2/20 0.41
LMNA P02545 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
CES1 P23141 1/20 0.40
NOTUM Q6P988 2/20 0.40
KMT2A Q03164 2/20 0.40
ADORA1 P30542 1/20 0.40
POLB P06746 2/20 0.39
HPGD P15428 1/20 0.39
AVPR2 P30518 1/20 0.38
OXTR P30559 1/20 0.38
AVPR1A P37288 1/20 0.38
MEN1 O00255 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24574306 0.99 KDM4E (0.56) KDM4EHTTSMN1; SMN2HSD17B3ALDH1A1
SCHEMBL25139324 0.89 KDM4E (0.59) KDM4EHTTSMN1; SMN2HSD17B3ALDH1A1
SCHEMBL27407147 0.85 HSD17B3 (0.56) KDM4EHTTSMN1; SMN2HSD17B3TSHR
SCHEMBL26076765 0.85 HSD17B3 (0.56) KDM4EHTTSMN1; SMN2HSD17B3TSHR
SCHEMBL26077004 0.80 HSD17B3 (0.41) KDM4EHTTSMN1; SMN2HSD17B3TSHR
SCHEMBL22652710 0.80 KDM4E (0.58) KDM4EHTTSMN1; SMN2HSD17B3ALDH1A1
SCHEMBL20829938 0.80 TSHR (0.47) KDM4EHTTSMN1; SMN2HSD17B3ALDH1A1
SCHEMBL24401170 0.79 MTNR1A (0.50) KDM4EHTTSMN1; SMN2TSHRNOTUM
SCHEMBL25016070 0.78 NOTUM (0.58) KDM4EHTTSMN1; SMN2ALDH1A1TSHR
SCHEMBL22102183 0.77 HSD17B3 (0.71) KDM4EHTTSMN1; SMN2HSD17B3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022108452-A1 TYROSINE-BASED ANTIBODY CONJUGATES SYNAFFIX B.V. (NL) 2022-05-27 WO disclosed